======= MTA2 ======= == Gene Information == * **Official Symbol**: MTA2 * **Official Name**: metastasis associated 1 family member 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9219|9219]] * **UniProt**: [[https://www.uniprot.org/uniprot/O94776|O94776]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MTA2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MTA2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603947|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May be involved in the regulation of gene expression as repressor and activator. The repression might be related to covalent modification of histone proteins. |GATA| |ELM2| |BAH| |NuRD complex| |histone deacetylase activity| |regulation of fibroblast migration| |RNA polymerase II repressing transcription factor binding| |histone deacetylase complex| |nucleosomal DNA binding| |DNA alkylation| |DNA methylation| |histone deacetylation| |protein deacetylation| |protein deacylation| |macromolecule deacylation| |RNA polymerase II transcription factor binding| |DNA methylation or demethylation| |transcription regulatory region sequence-specific DNA binding| |ATP-dependent chromatin remodeling| |DNA modification| |histone deacetylase binding| |chromatin assembly or disassembly| |chromatin remodeling| |regulation of signal transduction by p53 class mediator| |transcription factor complex| |nuclear chromatin| |transcription corepressor activity| |macromolecule methylation| |transcription coactivator activity| |methylation| |histone modification| |covalent chromatin modification| |protein-containing complex| |chromatin organization| |DNA metabolic process| |zinc ion binding| |regulation of cell migration| |negative regulation of transcription by RNA polymerase II| |regulation of cell motility| |regulation of locomotion| |regulation of cellular component movement| |chromosome organization| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |regulation of intracellular signal transduction| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |membrane| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-2.62| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-2.51| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|-2.28| |[[:results:exp463|Caffeine 2600μM R08 exp463]]|-2.18| |[[:results:exp417|Tubastatin-A 2.5μM R07 exp417]]|-1.99| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|-1.97| |[[:results:exp199|Etoposide 0.3μM R05 exp199]]|-1.92| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|1.7| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|1.73| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|1.78| |[[:results:exp433|LJH685 50μM R08 exp433]]|1.78| |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|1.79| |[[:results:exp333|All-trans-Retinoic-Acid 8μM R07 exp333]]|1.81| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|1.9| |[[:results:exp461|BS-181 20μM R08 exp461]]|1.92| |[[:results:exp326|CCT251545 20μM R07 exp326]]|1.96| |[[:results:exp183|IU1-C 25μM R04 exp183]]|1.96| |[[:results:exp438|NN-Diethyl-meta-toluamide 500μM R08 exp438]]|1.98| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|2.02| |[[:results:exp538|ZLN024 50μM R08 exp538]]|2.02| |[[:results:exp212|Phenformin 20μM R05 exp212]]|2.03| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|2.04| |[[:results:exp241|QNZ 0.01μM R05 exp241]]|2.06| |[[:results:exp209|Deguelin 0.15μM R05 exp209]]|2.13| |[[:results:exp59|UMK57 1μM R01 exp59]]|2.25| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|2.45| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|2.48| |[[:results:exp274|Citral 50μM R06 exp274]]|2.49| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|2.53| |[[:results:exp248|UM0131023 0.05μM R05 exp248]]|3.45| ^Gene^Correlation^ |[[:human genes:m:mbd3|MBD3]]|0.56| |[[:human genes:h:hdac1|HDAC1]]|0.535| |[[:human genes:h:hgc6.3|HGC6.3]]|0.525| |[[:human genes:g:gatad2a|GATAD2A]]|0.476| |[[:human genes:h:hdac2|HDAC2]]|0.441| |[[:human genes:r:rcor1|RCOR1]]|0.406| Global Fraction of Cell Lines Where Essential: 5/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/25| |breast|1/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|1/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|2/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2202 * **Expression level (log2 read counts)**: 7.92 {{:chemogenomics:nalm6 dist.png?nolink |}}